2025 NAACCR Board of Directors Election Results

By Mona Highsmith, BA | June 16, 2025

The NAACCR Nominating Committee is charged with encouraging volunteers to consider serving on the NAACCR Board of Directors and to accept eligible nominations for Board elections. For 2025, there were four key leadership roles on the Board of Directors to be filled: Treasurer and three Representatives-at-Large. Additionally, this year’s general election selected three individuals for…

Read More >

Call for Subject Matter Experts: Help Develop Central Registry Training!

By Jim Hofferkamp, BA, CTR | May 26, 2025

The NAACCR Professional Development Steering Committee’s Upkeep Work Group is developing a series of 14–15 online training modules to support central cancer registry professionals—and we need your expertise! We’re covering a wide range of topics, including: Reporting Requirements Casefinding Processing Incoming Records Edits & Consolidation Quality Control (QC) Geocoding Surveillance Activities Research File Development Have…

Read More >

Louisiana Amends Cancer Reporting Law and Modernizes Framework

By Xiao-Cheng Wu | May 19, 2025

In 2024, Louisiana enacted legislative amendments to its cancer reporting law to enhance the Louisiana Tumor Registry‘s (LTR) authority and modernize the state’s cancer surveillance framework. The revised law clarifies LTR’s authority to screen all pathology reports and medical records to identify reportable cancer cases and to request the electronic, real-time transmission of pathology reports,…

Read More >

Advancing Global Collaboration in Childhood Cancer Research: Data Resource Mapping and Federated Network Matrix

By Fernanda Michels | January 5, 2026

In November 2023, the US National Cancer Institute (NCI) (with support from NAACCR) and the French National Cancer Institute (INCa) co-sponsored the Paris Conference for an International Childhood Cancer Data Partnership. Organized within the framework of the first working group of the G7 Cancer Initiative and supported by the European Commission, the meeting brought together…

Read More >

An Interview with Our New RDU Chair

By Recinda Sherman, PhD, MPH, ODS-C | December 29, 2025

An Interview with our new Research and Date Use Committee Chair It was so much fun interviewing the RDU Co-Chairs last December that I decided to interview our newest Co-Chair, Angela Eckstrand, this December! Angela replaced Jeff Dowden (our resident rock star) from the Newfoundland Cancer Registry when his tenure ended. Yes, this means both…

Read More >

Writing Edits – An Approach for a New Central Registry Edit Writer

By Elaine Collins | December 22, 2025

Introduction Data relationships, electronic formatting, logical viewpoint – all come together in edits to support the collection of useful cancer information. The edits in the standard metafile realize standards that apply to data collected at the national level, but the same edit tools and processes are available to central registries to manage additional local data…

Read More >

Browse Sections

OUR MISSION

Actionable content that unites cancer registries.

The Narrative strives to provide you with information you can use to enhance and strengthen your cancer registry. Look to the Narrative for the latest cancer surveillance news, trends, advances in technology, and latest educational opportunities.

OUR VISION

Make every cancer count.

Cancer affects thousands of people across North America every year. Each cancer case must contribute to our knowledge and understanding so that we may reduce the burden of these diseases. Narrative provides a platform for the cancer surveillance community to collaborate and share data that will improve health outcomes.

CANCER REGISTRY SPOTLIGHT: MICHIGAN

Successful Linkage Between Registry Database and LexisNexis

In our ongoing commitment to enhance the quality and accessibility of data, we are thrilled to announce the successful linkage between our registry database and LexisNexis. This integration represents a significant step forward in streamlining our data processes and expanding our analytical capabilities.